A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytoma

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501423-25-00

Acronym

CV-GBLM-001

Enrollment

Registered

2023-03-24

Start date

2023-05-05

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgically Resected Glioblastoma (GBM) or Astrocytoma with a Molecular Signature of Unmethylated Glioblastoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026